Targeting Tumor Hypoxia With Hypoxia-Activated Prodrugs

被引：41
|
作者：
Yeh, Jen Jen [1 ]
Kim, William Y. [1 ]
机构：
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 13期
关键词：
PHASE-III TRIAL; PANCREATIC-CANCER; SOLID TUMORS; ANTITUMOR-ACTIVITY; CELL CARCINOMA; ONCOLOGY-GROUP; THERAPY; DOXORUBICIN; BREAST; ADENOCARCINOMA;
D O I：
10.1200/JCO.2014.60.0759
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1505 / 1508
页数：4
相关论文
共 50 条
  • [31] A Novel Model System for Understanding Anticancer Activity of Hypoxia-Activated Prodrugs
    Sun, Zhiyuan
    Zhang, Haoqi
    Wu, Jin
    Gao, Fangli
    Zhang, Congcong
    Hu, Xueyan
    Liu, Qiqi
    Wei, Yonghua
    Zhuang, Jie
    Huang, Xinglu
    MOLECULAR PHARMACEUTICS, 2020, 17 (06) : 2072 - 2082
  • [32] Role of hypoxia-activated prodrugs in combination with radiation therapy: An in silico approach
    Meaney, Cameron
    Powathil, Gibin G.
    Yaromina, Ala
    Dubois, Ludwig J.
    Lambin, Philippe
    Kohandel, Mohammad
    MATHEMATICAL BIOSCIENCES AND ENGINEERING, 2019, 16 (06) : 6257 - 6273
  • [33] Hypoxia-Activated Theragnostic Prodrugs (HATPs): Current State and Future Perspectives
    Bhuniya, Sankarprasad
    Vrettos, Eirinaios I.
    PHARMACEUTICS, 2024, 16 (04)
  • [34] Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer
    Sun, Jessica D.
    Liu, Qian
    Wang, Jingli
    Ahluwalia, Dharmendra
    Ferraro, Damien
    Wang, Yan
    Duan, Jian-Xin
    Ammons, W. Steve
    Curd, John G.
    Matteucci, Mark D.
    Hart, Charles P.
    CLINICAL CANCER RESEARCH, 2012, 18 (03) : 758 - 770
  • [35] Hepatic hypoxia-activated intra-arterial therapy: effect of selective targeting of hypoxia in a rabbit liver tumor model
    Duran, Rafael
    Mirpour, Sahar
    Pekurovsky, Vasily
    Ganapathy-Kanniappan, Shanmugasundaram
    Brayton, Cory F.
    Cornish, Toby C.
    Gorodetski, Boris
    Chapiro, Julius
    Schernthaner, Ruediger
    Frangakis, Constantine
    Lin, MingDe
    Sun, Jessica D.
    Hart, Charles P.
    Geschwind, Jean-Francois H.
    CANCER RESEARCH, 2015, 75
  • [36] Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
    Guise, Christopher P.
    Mowday, Alexandra M.
    Ashoorzadeh, Amir
    Yuan, Ran
    Lin, Wan-Hua
    Wu, Dong-Hai
    Smaill, Jeff B.
    Patterson, Adam V.
    Ding, Ke
    CHINESE JOURNAL OF CANCER, 2014, 33 (02) : 80 - 86
  • [37] Hypoxia-activated prodrugs of phenolic olaparib analogues for tumour-selective chemosensitisation
    Wong, Way W.
    O'Brien-Gortner, Sophia F.
    Anderson, Robert F.
    Wilson, William R.
    Hay, Michael P.
    Dickson, Benjamin D.
    RSC MEDICINAL CHEMISTRY, 2023, 14 (07): : 1309 - 1330
  • [38] Design, synthesis, and biological evaluation of pyrrolobenzodiazepine-containing hypoxia-activated prodrugs
    Dragovich, Peter S.
    Broccatelli, Fabio
    Chen, Jinhua
    Fan, Peter
    Le, Hoa
    Mao, Weiguang
    Pillow, Thomas H.
    Polson, Andrew G.
    Wai, John
    Xu, Zijin
    Yao, Hui
    Zhang, Donglu
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (23) : 5300 - 5304
  • [39] Cytotoxicity of Co3+ Complexes Candidates for Hypoxia-activated Antitumor Prodrugs
    Rios, Rafaella Rebecchi
    Pereira, Marcos Dias
    Scarpellini, Marciela
    JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY, 2017, 22 : S102 - S102
  • [40] Significance of Specific Oxidoreductases in the Design of Hypoxia-Activated Prodrugs and Fluorescent Turn off-on Probes for Hypoxia Imaging
    Janczy-Cempa, Ewelina
    Mazuryk, Olga
    Kania, Agnieszka
    Brindell, Malgorzata
    CANCERS, 2022, 14 (11)
12345